TY - JOUR
T1 - Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection
AU - the BioBank Japan Project
AU - FinnGen Consortium
AU - Zekavat, Seyedeh M.
AU - Lin, Shu Hong
AU - Bick, Alexander G.
AU - Liu, Aoxing
AU - Paruchuri, Kaavya
AU - Wang, Chen
AU - Uddin, Md Mesbah
AU - Ye, Yixuan
AU - Yu, Zhaolong
AU - Liu, Xiaoxi
AU - Kamatani, Yoichiro
AU - Bhattacharya, Romit
AU - Pirruccello, James P.
AU - Pampana, Akhil
AU - Loh, Po Ru
AU - Kohli, Puja
AU - McCarroll, Steven A.
AU - Kiryluk, Krzysztof
AU - Neale, Benjamin
AU - Ionita-Laza, Iuliana
AU - Engels, Eric A.
AU - Brown, Derek W.
AU - Smoller, Jordan W.
AU - Green, Robert
AU - Karlson, Elizabeth W.
AU - Lebo, Matthew
AU - Ellinor, Patrick T.
AU - Weiss, Scott T.
AU - Daly, Mark J.
AU - Koyama, Satoshi
AU - Ito, Kaoru
AU - Momozawa, Yukihide
AU - Matsuda, Koichi
AU - Yamanashi, Yuji
AU - Furukawa, Yoichi
AU - Morisaki, Takayuki
AU - Murakami, Yoshinori
AU - Muto, Kaori
AU - Nagai, Akiko
AU - Obara, Wataru
AU - Yamaji, Ken
AU - Takahashi, Kazuhisa
AU - Asai, Satoshi
AU - Takahashi, Yasuo
AU - Suzuki, Takao
AU - Sinozaki, Nobuaki
AU - Yamaguchi, Hiroki
AU - Minami, Shiro
AU - Terao, Chikashi
AU - Terao, Chikashi
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2021/6
Y1 - 2021/6
N2 - Age is the dominant risk factor for infectious diseases, but the mechanisms linking age to infectious disease risk are incompletely understood. Age-related mosaic chromosomal alterations (mCAs) detected from genotyping of blood-derived DNA, are structural somatic variants indicative of clonal hematopoiesis, and are associated with aberrant leukocyte cell counts, hematological malignancy, and mortality. Here, we show that mCAs predispose to diverse types of infections. We analyzed mCAs from 768,762 individuals without hematological cancer at the time of DNA acquisition across five biobanks. Expanded autosomal mCAs were associated with diverse incident infections (hazard ratio (HR) 1.25; 95% confidence interval (CI) = 1.15–1.36; P = 1.8 × 10−7), including sepsis (HR 2.68; 95% CI = 2.25–3.19; P = 3.1 × 10−28), pneumonia (HR 1.76; 95% CI = 1.53–2.03; P = 2.3 × 10−15), digestive system infections (HR 1.51; 95% CI = 1.32–1.73; P = 2.2 × 10−9) and genitourinary infections (HR 1.25; 95% CI = 1.11–1.41; P = 3.7 × 10−4). A genome-wide association study of expanded mCAs identified 63 loci, which were enriched at transcriptional regulatory sites for immune cells. These results suggest that mCAs are a marker of impaired immunity and confer increased predisposition to infections.
AB - Age is the dominant risk factor for infectious diseases, but the mechanisms linking age to infectious disease risk are incompletely understood. Age-related mosaic chromosomal alterations (mCAs) detected from genotyping of blood-derived DNA, are structural somatic variants indicative of clonal hematopoiesis, and are associated with aberrant leukocyte cell counts, hematological malignancy, and mortality. Here, we show that mCAs predispose to diverse types of infections. We analyzed mCAs from 768,762 individuals without hematological cancer at the time of DNA acquisition across five biobanks. Expanded autosomal mCAs were associated with diverse incident infections (hazard ratio (HR) 1.25; 95% confidence interval (CI) = 1.15–1.36; P = 1.8 × 10−7), including sepsis (HR 2.68; 95% CI = 2.25–3.19; P = 3.1 × 10−28), pneumonia (HR 1.76; 95% CI = 1.53–2.03; P = 2.3 × 10−15), digestive system infections (HR 1.51; 95% CI = 1.32–1.73; P = 2.2 × 10−9) and genitourinary infections (HR 1.25; 95% CI = 1.11–1.41; P = 3.7 × 10−4). A genome-wide association study of expanded mCAs identified 63 loci, which were enriched at transcriptional regulatory sites for immune cells. These results suggest that mCAs are a marker of impaired immunity and confer increased predisposition to infections.
UR - https://www.scopus.com/pages/publications/85107820065
UR - https://www.scopus.com/pages/publications/85107820065#tab=citedBy
U2 - 10.1038/s41591-021-01371-0
DO - 10.1038/s41591-021-01371-0
M3 - Article
C2 - 34099924
AN - SCOPUS:85107820065
SN - 1078-8956
VL - 27
SP - 1012
EP - 1024
JO - Nature Medicine
JF - Nature Medicine
IS - 6
ER -